Investors Contact Careers Research Request

Interpace Biosciences, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
  • Patients
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

Oct 17, 2019

Interpace Named to ‘Most Admired Companies’ List

Oct 15, 2019

Interpace Announces New Contracts with Multiple Blue Cross Blue Shield Plans

Sep 30, 2019

Interpace to Present at The Ladenburg Thalmann 2019 Healthcare Conference

Sep 18, 2019

Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China

Sep 16, 2019

Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright

Sep 6, 2019

Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update

Aug 13, 2019

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

Aug 6, 2019

Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan

Jul 31, 2019

Interpace Announces Contract with Blue Shield of California for ThyGeNEXT® & ThyraMIR®

Jul 29, 2019
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...19
    © 2021 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    • Twitter
    • Facebook
    • Linkedin